• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2025 Jun 17;122(24):e2426528122.
doi: 10.1073/pnas.2426528122. Epub 2025 Jun 12. SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses

Allen Caobi[SUP] 1 2 [/SUP], Chia-Ming Su[SUP] 1 2 [/SUP], Christian M Beusch[SUP] 3 4 [/SUP], Devin Kenney[SUP] 1 2 [/SUP], Tamarand L Darling[SUP] 5 6 7 [/SUP], Shuchen Feng[SUP] 8 [/SUP], Marc Semaan[SUP] 1 2 [/SUP], Alan Wacquiez[SUP] 1 2 [/SUP], Nathan L Sanders[SUP] 9 10 [/SUP], Ena S Tully[SUP] 11 [/SUP], Da-Yuan Chen[SUP] 1 2 [/SUP], Monika Evdokimova[SUP] 8 [/SUP], Zhen Ding[SUP] 1 2 [/SUP], Dakota Jones[SUP] 9 12 13 [/SUP], Konstantinos-Dionysios Alysandratos[SUP] 9 12 13 [/SUP], Joseph P Mizgerd[SUP] 2 9 10 13 [/SUP], Robert N Kirchdoerfer[SUP] 11 [/SUP], Darrell N Kotton[SUP] 9 12 13 [/SUP], Florian Douam[SUP] 2 10 [/SUP], Nicholas A Crossland[SUP] 2 10 14 [/SUP], Adrianus C M Boon[SUP] 5 6 7 [/SUP], David E Gordon[SUP] 3 [/SUP], Susan C Baker[SUP] 8 [/SUP], Mohsan Saeed[SUP] 1 2 [/SUP]



Affiliations
Abstract

SARS-CoV-2 encodes numerous virulence factors, yet their precise mechanisms of action remain unknown. We provide evidence that the SARS-CoV-2 nonstructural protein 15 (nsp15) enhances viral virulence by suppressing the production of viral double-stranded (dsRNA), a potent inducer of antiviral signaling. The viral variants lacking nsp15 endoribonuclease activity elicited higher innate immune responses and exhibited reduced replication in human stem cell-derived lung alveolar type II epithelial cells, as well as in the lungs of infected hamsters. Consistently, these variants caused significantly less weight loss and mortality compared to wild-type (WT) virus in K18-hACE2 mice. Mechanistically, the cells infected with nsp15 mutants accumulated more viral dsRNA, causing enhanced stimulation of the interferon pathway. Chemical inhibition of interferon signaling dampened immune responses to nsp15 mutants and restored their replication to levels similar to the WT virus. These findings indicate that the endoribonuclease activity of nsp15 contributes to viral virulence by limiting the accumulation of viral dsRNA, thereby allowing robust replication with reduced activation of the host innate immune response.


 
Back
Top